Literature DB >> 4480883

Objective evaluation of an antacid with unusual properties.

G L Beckloff, J H Chapman, P Shiverdecker.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4480883     DOI： 10.1002/j.1552-4604.1972.tb00030.x

Source DB:  PubMed          Journal:  J Clin Pharmacol New Drugs        ISSN： 0021-9754


× No keyword cloud information.
  4 in total

1.  Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal-strength antacid.

Authors:  D O Castell; C B Dalton; D Becker; J Sinclair; J A Castell
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

2.  Alginate controls heartburn in patients with erosive and nonerosive reflux disease.

Authors:  Edoardo Savarino; Nicola de Bortoli; Patrizia Zentilin; Irene Martinucci; Luca Bruzzone; Manuele Furnari; Santino Marchi; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

3.  Combination of cimetidine and alginic acid: an improvement in the treatment of oesophageal reflux disease. Cooperative Oesophageal Group.

Authors: 
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

4.  Comparison of the combination of cholestyramine/alginates with placebo in the treatment of postgastrectomy biliary reflux gastritis.

Authors:  J J Nicolai; P Speelman; G N Tytgat; J van der Stadt
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.